Lifeward Ltd.

LFWD

$7.10

-2.20%

N/A-$0.16

Healthcare

Medical - Devices

NASDAQ

Active Trading

Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are ...

Insider Transactions of LFWD

Acquisitions (A)

Since Mar 25, 2026

Disposals (D)

Since Mar 25, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Sep 1, 2026	Hexter Joshua	—	—	—	0	—
Aug 20, 2026	Gabay Avraham	director	Ordinary Shares, no par value per share	A	13,643	—
Aug 20, 2026	Gabay Avraham	director:	—	—	0	—
Aug 14, 2026	Greenwald Yonason	director	Ordinary Shares, no par value per share	A	6,711	—
Aug 14, 2026	Greenwald Yonason	director:	—	—	0	—

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

35,354

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

ORAMED PHARMACEUTICALS INC.

10 percent owner • 3 txns

Gabay Avraham

director • 2 txns

Greenwald Yonason

director • 2 txns

Rose Keith Dale

officer: Chief Medical Officer • 2 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Sep 1, 2026	Hexter Joshua	—	—	—	0	—	—
Aug 20, 2026	Gabay Avraham	director	Ordinary Shares, no par value per share	A	13,643	—	—
Aug 20, 2026	Gabay Avraham	director:	—	—	0	—	—
Aug 14, 2026	Greenwald Yonason	director	Ordinary Shares, no par value per share	A	6,711	—	—
Aug 14, 2026	Greenwald Yonason	director:	—	—	0	—	—
May 1, 2026	Rose Keith Dale	officer: Chief Medical Officer	Ordinary Shares, no par value per share	A	15,000	—	—
May 1, 2026	Rose Keith Dale	officer: Chief Medical Officer	Ordinary Shares, no par value per share	—	0	—	—
Mar 25, 2026	ORAMED PHARMACEUTICALS INC.	10 percent owner	Ordinary Shares	—	0	—	—
Mar 25, 2026	ORAMED PHARMACEUTICALS INC.	10 percent owner	Warrants (right to buy)	—	1,006,113	—	—
Mar 25, 2026	ORAMED PHARMACEUTICALS INC.	10 percent owner	Warrants (right to buy)	—	1,666,666	$5.40	$8,999,996.40

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer